algorithms.eod_public.1.1.schemas.plasma_cell_myeloma.json Maven / Gradle / Ivy
Go to download
Show more of this group Show more artifacts with this name
Show all versions of staging-client-java Show documentation
Show all versions of staging-client-java Show documentation
A cancer staging client library
{
"id" : "plasma_cell_myeloma",
"algorithm" : "eod_public",
"version" : "1.1",
"name" : "Plasma Cell Myeloma",
"title" : "Plasma Cell Myeloma",
"notes" : "9732 Multiple myeloma \n\n**Note 1:** The following sources were used in the development of this schema\n* SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf)\n* SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/)\n* Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx \n* Chapter 82 *Plasma Cell Myeloma and Plasma Cell Disorder*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois.\n\n**Note 2:** TNM data elements are not defined for this schema. TNM Stage Group is defined for multiple myeloma only (see Note 3) \n\n**Note 3:** The *Revised International Staging System (RISS)* is being used to stage plasma cell myeloma/multiple myeloma (9732). The following variables must be collected at the time of diagnosis for staging:\n* High Risk Cytogenetics [NAACCR Data Item #3857]\n* LDH Pretreatment Level [NAACCR Data Item #3932]\n* Serum Albumin Pretreatment Level [NAACCR Data Item #3930]\n* Serum Beta-2 Microglobulin Pretreatment Level [NAACCR Data Item #3931]",
"schema_selection_table" : "schema_selection_myeloma_plasma_cell_disorder",
"inputs" : [ {
"key" : "year_dx",
"name" : "Year of Diagnosis",
"naaccr_item" : 390,
"table" : "year_dx_validation",
"used_for_staging" : false
}, {
"key" : "site",
"name" : "Primary Site",
"naaccr_item" : 400,
"table" : "primary_site",
"used_for_staging" : true
}, {
"key" : "hist",
"name" : "Histology",
"naaccr_item" : 522,
"table" : "histology",
"used_for_staging" : true
}, {
"key" : "discriminator_1",
"name" : "Schema Discriminator 1",
"naaccr_item" : 3926,
"default" : "0",
"table" : "multiple_myeloma_terminology_20875",
"used_for_staging" : true,
"metadata" : [ "COC_REQUIRED", "NPCR_REQUIRED", "SSDI", "CCCR_REQUIRED", "SEER_REQUIRED" ]
}, {
"key" : "size_clin",
"name" : "Tumor Size Clinical",
"naaccr_item" : 752,
"table" : "tumor_size_clinical_60979",
"used_for_staging" : false
}, {
"key" : "size_path",
"name" : "Tumor Size Pathological",
"naaccr_item" : 754,
"table" : "tumor_size_pathological_25597",
"used_for_staging" : false
}, {
"key" : "size_summary",
"name" : "Tumor Size Summary",
"naaccr_item" : 756,
"default" : "999",
"table" : "tumor_size_summary_63115",
"used_for_staging" : false
}, {
"key" : "nodes_pos",
"name" : "Regional Nodes Positive",
"naaccr_item" : 820,
"default" : "99",
"table" : "nodes_pos_dna_91511",
"used_for_staging" : false
}, {
"key" : "nodes_exam",
"name" : "Regional Nodes Examined",
"naaccr_item" : 830,
"default" : "99",
"table" : "nodes_exam_dna_95635",
"used_for_staging" : false
}, {
"key" : "eod_primary_tumor",
"name" : "EOD Primary Tumor",
"naaccr_item" : 772,
"default" : "999",
"table" : "extension_bgc",
"used_for_staging" : true
}, {
"key" : "eod_regional_nodes",
"name" : "EOD Regional Nodes",
"naaccr_item" : 774,
"default" : "888",
"table" : "nodes_dna",
"used_for_staging" : true
}, {
"key" : "eod_mets",
"name" : "EOD Mets",
"naaccr_item" : 776,
"default" : "88",
"table" : "mets_hna",
"used_for_staging" : true
}, {
"key" : "ss2018",
"name" : "SS2018",
"naaccr_item" : 764,
"table" : "ss2018_44993",
"used_for_staging" : false
}, {
"key" : "grade_clin",
"name" : "Grade Clinical",
"naaccr_item" : 3843,
"default" : "8",
"table" : "grade_clinical_18316",
"used_for_staging" : false,
"metadata" : [ "NPCR_REQUIRED", "COC_REQUIRED", "SSDI", "CCCR_REQUIRED", "SEER_REQUIRED" ]
}, {
"key" : "grade_path",
"name" : "Grade Pathological",
"naaccr_item" : 3844,
"default" : "8",
"table" : "grade_pathological_73388",
"used_for_staging" : false,
"metadata" : [ "NPCR_REQUIRED", "COC_REQUIRED", "SSDI", "CCCR_REQUIRED", "SEER_REQUIRED" ]
}, {
"key" : "grade_post_therapy",
"name" : "Grade Post Therapy",
"naaccr_item" : 3845,
"table" : "grade_post_therapy_72642",
"used_for_staging" : false,
"metadata" : [ "COC_REQUIRED", "NPCR_REQUIRED", "SSDI", "CCCR_REQUIRED", "SEER_REQUIRED" ]
}, {
"key" : "high_risk_cytogenetics",
"name" : "High Risk Cytogenetics",
"naaccr_item" : 3857,
"default" : "9",
"table" : "high_risk_cytogenetics_97806",
"used_for_staging" : false,
"metadata" : [ "NPCR_REQUIRED", "COC_REQUIRED", "SSDI", "CCCR_REQUIRED", "SEER_REQUIRED" ]
}, {
"key" : "serum_alb_pretx_level",
"name" : "Serum Albumin Pretreatment Level",
"naaccr_item" : 3930,
"default" : "9",
"table" : "serum_alb_pretx_level_58159",
"used_for_staging" : false,
"metadata" : [ "NPCR_REQUIRED", "COC_REQUIRED", "SSDI", "CCCR_REQUIRED", "SEER_REQUIRED" ]
}, {
"key" : "b2_microglob_pretx_level",
"name" : "Serum Beta-2 Microglobulin Pretreatment Level",
"naaccr_item" : 3931,
"default" : "9",
"table" : "b2_microglob_pretx_level_83264",
"used_for_staging" : false,
"metadata" : [ "COC_REQUIRED", "NPCR_REQUIRED", "SSDI", "CCCR_REQUIRED", "SEER_REQUIRED" ]
}, {
"key" : "ldh_pretx_level",
"name" : "LDH (Lactate Dehydrogenase) Pretreatment Level",
"naaccr_item" : 3869,
"default" : "9",
"table" : "ldh_pretreatment_level_82697",
"used_for_staging" : false,
"metadata" : [ "COC_REQUIRED", "NPCR_REQUIRED", "SSDI", "CCCR_REQUIRED", "SEER_REQUIRED" ]
} ],
"outputs" : [ {
"key" : "naaccr_schema_id",
"name" : "Schema ID",
"naaccr_item" : 3800,
"default" : "00821"
}, {
"key" : "ajcc_id",
"name" : "AJCC ID",
"naaccr_item" : 995,
"default" : "XX"
}, {
"key" : "derived_version",
"name" : "Derived Version",
"default" : "{{ctx_alg_version}}"
}, {
"key" : "eod_2018_t",
"name" : "Derived EOD 2018 T",
"naaccr_item" : 785,
"default" : "88"
}, {
"key" : "eod_2018_n",
"name" : "Derived EOD 2018 N",
"naaccr_item" : 815,
"default" : "88"
}, {
"key" : "eod_2018_m",
"name" : "Derived EOD 2018 M",
"naaccr_item" : 795,
"default" : "88"
}, {
"key" : "eod_2018_stage_group",
"name" : "Derived EOD 2018 Stage Group",
"naaccr_item" : 818,
"default" : "88"
}, {
"key" : "ss2018_derived",
"name" : "Derived Summary Stage 2018",
"naaccr_item" : 762,
"default" : "9"
} ],
"mappings" : [ {
"id" : "ajcc_chapter_calculation",
"name" : "AJCC Chapter Calculation",
"tables" : [ {
"id" : "ajcc_chapter_calculation_16971",
"inputs" : [ "site", "discriminator_1" ],
"outputs" : [ "ajcc_id" ]
} ]
}, {
"id" : "summary_stage_2018",
"name" : "Summary Stage 2018",
"tables" : [ {
"id" : "extension_bgc",
"inputs" : [ "eod_primary_tumor" ],
"outputs" : [ "eod_2018_t", "ss2018_t" ]
}, {
"id" : "nodes_dna",
"inputs" : [ "eod_regional_nodes" ],
"outputs" : [ "eod_2018_n", "ss2018_n" ]
}, {
"id" : "mets_hna",
"inputs" : [ "eod_mets" ],
"outputs" : [ "eod_2018_m", "ss2018_m" ]
}, {
"id" : "summary_stage_lymphoma_25139",
"inputs" : [ "ss2018_m", "ss2018_n", "ss2018_t" ],
"outputs" : [ "ss2018_derived" ]
} ]
} ],
"involved_tables" : [ "multiple_myeloma_terminology_20875", "grade_post_therapy_72642", "ajcc_chapter_calculation_16971", "ss2018_44993", "high_risk_cytogenetics_97806", "b2_microglob_pretx_level_83264", "tumor_size_pathological_25597", "summary_stage_lymphoma_25139", "extension_bgc", "tumor_size_clinical_60979", "nodes_exam_dna_95635", "serum_alb_pretx_level_58159", "primary_site", "ldh_pretreatment_level_82697", "histology", "schema_selection_myeloma_plasma_cell_disorder", "year_dx_validation", "mets_hna", "tumor_size_summary_63115", "grade_clinical_18316", "grade_pathological_73388", "nodes_dna", "nodes_pos_dna_91511" ],
"on_invalid_input" : "CONTINUE",
"last_modified" : "2018-04-19T21:52:51.152Z"
}